Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115043775B reveals a novel chiral pyridoxal catalyst enabling biomimetic aldol reactions for beta-amino alcohol synthesis with high enantioselectivity and scalable manufacturing potential.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Patent CN1166672C details a novel Ru-H4-BINAP-diamine complex for asymmetric hydrogenation, offering high enantioselectivity and cost-effective manufacturing for chiral alcohol intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN110526944A reveals high-efficiency Ru catalyst for asymmetric transfer hydrogenation, offering cost reduction and supply reliability.
Patent CN112624901B details a novel refining method for chiral alcohols using polymer-supported catalysts and specific ether solvents, ensuring >99% purity for API manufacturing.
Patent CN117886789A reveals efficient Ir-catalyzed synthesis. Offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability for global buyers.
Patent CN108863787A details efficient asymmetric hydrogenation for chiral alcohols. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Industrial process for chiral 2-chloro-1-(2,4-dichlorophenyl) ethyl alcohol. High purity, scalable, cost-effective supply for antifungal API manufacturing.
Patent CN117567288A details a novel asymmetric hydrogenation process for chiral alcohols, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102675049B details a ZnBr2-promoted synthesis of optically active axially chiral alpha-allenols. Offers high ee values and scalable routes for pharma intermediates.
Patent CN113322291A details an enzymatic route for high-purity chiral amino alcohols, offering cost-effective solutions for veterinary antibiotic manufacturing.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Patent CN104232696B enables high ee biocatalysis for pharmaceutical intermediates with significant cost and supply chain advantages for global buyers.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN110129382B details a green enzymatic route for high-purity chiral alcohols, offering significant supply chain stability and cost efficiency for pharmaceutical intermediates.